Class 2 Medicines recall: Clexane 4,000 IU (40mg) /0.4ml Syringes (Pharmaram Ltd)

Class 2 Medicines recall: Clexane 4,000 IU (40mg) /0.4ml Syringes (Pharmaram Ltd)

August 4, 2020

Class 2 MHRA medicines recall – Clexane 4,000 IU (40mg) /0.4ml Syringes (Pharmaram Ltd) PLPI 33652/0067 

Drug alert number: EL (20)A/37

Date issued: 04 August 2020

The Medicines and Health products Regulatory Agency (MHRA) has issued a class 2 medicines recall for:

Clexane 4,000 IU (40mg) /0.4ml Syringes (Pharmaram Ltd) PLPI 33652/0067 

Pharmaram Ltd has informed the MHRA that the batch listed below of Clexane 4,000IU (40mg)/0.4ml syringes has an error on the labelling affixed to the plastic blister packaging encasing the syringe. The label incorrectly states “Clexane 6,000IU (60mg)/0.6ml Syringes”, when it should have stated “Clexane 4,000IU (40mg)/0.4ml Syringes”. The outer carton states the correct strength; the batch number and expiry dates are also correct and match the details on the labelling.

Batch Number Expiry Date Pack Size  First Distributed
CCL67G/D3 31/10/2022 10 syringes per pack 16/07/2020

Advice for healthcare professionals

  • Stop supplying the above products immediately and remove from the shelves within your pharmacy/store. Quarantine all remaining stock and return these to your supplier using your
    supplier’s approved process.
  • Patients who have been supplied this batch of Clexane 4,000IU (40mg)/0.4ml Syringes should be informed that the error is only with the labelling on the plastic blister packaging encasing the syringe.

Further information

Full drug alert can be viewed here.

For stock control queries please contact:
Pharmaram Ltd
Austin Chambers
Email: austin@dixpharm.com
Tel: +44 (0) 1530 410920
Mob: +44 (0) 7944 664400

For any medical information enquires please contact:
Pharmaram Ltd
Email: quality@dixpharm.com
Tel: +44 (0) 1530 410920



Posted in: ,


More Latest News >

Updated IPC guidance published

NHS England and NHS Improvement (NHSE&I) has published a letter to support NHS service providers including community pharmacy contractors, to...